-
-
-
-
-
-
-
Verrica Pharmaceuticals (VRCA) Amends Collaboration and License Agreement with Torii Pharmaceutical to Fund Global Pivotal Phase 3 Trial of YCANTH
-
-
-
-
-
-
-
Silo Pharma (SILO) to Participate in FDA Meeting Exploring Emerging Therapeutic Interest in Ketamine
-
-
-
-
-
-
-
Pliant Therapeutics (PLRX) Reports Positive Topline Data from a Phase 2a Collagen PET Imaging Trial
-
-
-
-
-
-
-
Merus N.V. (MRUS) Reports Petosemtamab Granted FDA Breakthrough Therapy Designation
-
-
-
-
-
-
-
Fractyl Health (GUTS) Presents Clinical Update on Revita German Real-World Registry for Patients With Advanced Type 2 Diabetes
-
-
-
-
-
-
-
Aethlon Medical (AEMD) Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma
-
-
-
-
-
-
-
Kite (GILD) and Arcellx (ACLX) Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
-
67,068 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.